Literature DB >> 9746577

Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation.

P Mastroeni1, J A Harrison, J H Robinson, S Clare, S Khan, D J Maskell, G Dougan, C E Hormaeche.   

Abstract

The attenuated S. typhimurium SL3261 (aroA) strain causes mild infections in BALB/c mice. We were able to exacerbate the disease by administering anti-interleukin-12 (IL-12) antibodies, resulting in bacterial counts in the spleens and livers of anti-IL-12-treated mice that were 10- to 100-fold higher than the ones normally observed in premortem mice; yet the animals showed only mild signs of illness. Nevertheless, they eventually died of a slow, progressive disease. Mice infected with salmonellae become hypersusceptible to endotoxin. We found that IL-12 neutralization prevented the death of infected mice following subcutaneous injection of lipopolysaccharide. Granulomatous lesions developed in the spleens and livers of control animals, as opposed to a widespread infiltration of mononuclear cells seen in the organs of anti-IL-12-treated mice. In the latter (heavily infected), salmonellae were seen within mononuclear cells, indicating an impairment of the bactericidal or bacteriostatic ability of the phagocytes in the absence of biologically active IL-12. Gamma interferon (IFN-gamma) levels were reduced in the sera and tissue homogenates from anti-IL-12-treated mice compared to those in control animals. Furthermore, fluorescence-activated cell sorter analysis on spleen cells showed that IL-12 neutralization impaired the upregulation of I-Ad/I-Ed antigens on macrophages from infected mice. Inducible nitric oxide synthase and IFN-gamma mRNA production was down-regulated in anti-IL-12-treated mice, which also showed an increased production of IL-10 mRNA and a decrease in nitric oxide synthase activity in the tissues. Administration of recombinant IFN-gamma to anti-IL-12-treated mice was able to restore host resistance, granuloma formation, and expression of major histocompatibility complex class II antigens in F4/80(+) and CD11b+ spleen cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9746577      PMCID: PMC108588          DOI: 10.1128/IAI.66.10.4767-4776.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.

Authors:  S K Hoiseth; B A Stocker
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

2.  IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis.

Authors:  L Romani; A Mencacci; L Tonnetti; R Spaccapelo; E Cenci; P Puccetti; S F Wolf; F Bistoni
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

3.  Toxicity of lipopolysaccharide and of soluble extracts of Salmonella typhimurium in mice immunized with a live attenuated aroA salmonella vaccine.

Authors:  P Mastroeni; B Villarreal-Ramos; J A Harrison; R Demarco de Hormaeche; C E Hormaeche
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

4.  Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

Authors:  R T Gazzinelli; S Hieny; T A Wynn; S Wolf; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

5.  Studies on the role of interleukin-12 in acute murine toxoplasmosis.

Authors:  C A Hunter; E Candolfi; C Subauste; V Van Cleave; J S Remington
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

6.  Effect of late administration of anti-TNF alpha antibodies on a Salmonella infection in the mouse model.

Authors:  P Mastroeni; B Villarreal-Ramos; C E Hormaeche
Journal:  Microb Pathog       Date:  1993-06       Impact factor: 3.738

7.  Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma.

Authors:  C S Tripp; M K Gately; J Hakimi; P Ling; E R Unanue
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

Review 8.  Interleukin-12.

Authors:  M J Brunda
Journal:  J Leukoc Biol       Date:  1994-02       Impact factor: 4.962

9.  In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin.

Authors:  K L Bost; J D Clements
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

10.  Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.

Authors:  J P Sypek; C L Chung; S E Mayor; J M Subramanyam; S J Goldman; D S Sieburth; S F Wolf; R G Schaub
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  52 in total

1.  Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.

Authors:  Rezwanul Wahid; Rosangela Salerno-Gonçalves; Carol O Tacket; Myron M Levine; Marcelo B Sztein
Journal:  Vaccine       Date:  2006-11-03       Impact factor: 3.641

Review 2.  A dynamic view of the spread and intracellular distribution of Salmonella enterica.

Authors:  Pietro Mastroeni; Andrew Grant; Olivier Restif; Duncan Maskell
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

3.  Coactivating signals for the hepatic lymphocyte gamma interferon response to Francisella tularensis.

Authors:  Jason R Wickstrum; Kee-Jong Hong; Sirosh Bokhari; Natalie Reed; Nicholas McWilliams; Rebecca T Horvat; Michael J Parmely
Journal:  Infect Immun       Date:  2006-12-18       Impact factor: 3.441

4.  Increased sensitivity to Salmonella enterica serovar Typhimurium infection in mice undergoing withdrawal from morphine is associated with suppression of interleukin-12.

Authors:  Pu Feng; Qiana M Wilson; Joseph J Meissler; Martin W Adler; Toby K Eisenstein
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

5.  TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica.

Authors:  Tom A Barr; Sheila Brown; Pietro Mastroeni; David Gray
Journal:  J Immunol       Date:  2010-07-30       Impact factor: 5.422

Review 6.  Salmonella effector proteins and host-cell responses.

Authors:  C V Srikanth; Regino Mercado-Lubo; Kelly Hallstrom; Beth A McCormick
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

Review 7.  Animal Models for Salmonellosis: Applications in Vaccine Research.

Authors:  Ellen E Higginson; Raphael Simon; Sharon M Tennant
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

8.  Gamma interferon-independent effects of interleukin-12 on immunity to Salmonella enterica serovar Typhimurium.

Authors:  Jason D Price; Kim R Simpfendorfer; Radhakrishnam R Mantena; James Holden; William R Heath; Nico van Rooijen; Richard A Strugnell; Odilia L C Wijburg
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

9.  Oral immunization with attenuated Salmonella enterica serovar Typhimurium encoding Cryptosporidium parvum Cp23 and Cp40 antigens induces a specific immune response in mice.

Authors:  Alvaro J Benitez; Nina McNair; Jan R Mead
Journal:  Clin Vaccine Immunol       Date:  2009-07-15

10.  Early interferon-γ production in human lymphocyte subsets in response to nontyphoidal Salmonella demonstrates inherent capacity in innate cells.

Authors:  Tonney S Nyirenda; Anna E Seeley; Wilson L Mandala; Mark T Drayson; Calman A MacLennan
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.